罗沙沙斯塔特对带有宏炎的脏贫血:一项回顾性队列研究
Yan Tu1, Zuo-Lin Li1, Hong Liu1
1Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing, China.
Kidney diseases (Basel, Switzerland)
|June 5, 2024
概括
罗沙杜沙特有效治疗脏贫血,即使在有系统性宏观炎症的患者中也是如此. 这种一流的药物改善了慢性病患者的所有炎症组的血红蛋白和铁水平.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 血液学 血液学 血液学
背景情况:
- 慢性脏病 (CKD) 中脏贫血很常见.
- 系统性炎症使贫血治疗复杂化.
- 罗沙杜沙特是治疗脏贫血的第一类药物,在微炎症中显示出有效性.
研究的目的:
- 为了评估roxadustat在患有全身性宏观炎症的贫症患者的疗效.
- 为了比较roxadustat在不同炎症水平 (非炎症,微炎症,宏炎症) 上的影响.
主要方法:
- 107名CKD患者根据高灵敏度C反应蛋白 (hsCRP) 水平被分为三组.
- 患者每周服用口服罗沙杜沙特三次,持续52周.
- 主要终点:血红蛋白水平的变化;次要终点:第12周的血红蛋白反应率.
主要成果:
- 在所有组 (NI,MI,MA) 中,Roxadustat显著增加了血红蛋白水平,没有显著差异.
- 宏观炎症组中的血红蛋白反应率与非炎症组没有显著差异.
- 在所有组中,Roxadustat改善了铁的参数 (费里丁,血清铁,TIBC).
结论:
- 罗沙杜沙特在治疗贫血方面是有效的,包括系统性宏观炎症的病例.
- 药物对血红蛋白和铁代谢的疗效在不同程度的炎症中是一致的.
- 罗沙杜沙特代表了对患有贫血和炎症的慢性病患者的可行的治疗选择.
相关概念视频
01:25Antihypertensive Drugs: Direct Renin Inhibitors
585
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
585
01:11Renal Failure: Dose Adjustments
84
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
84
01:17Factors Affecting Renal Clearance: Renal Impairment
84
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
84
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
421
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
421